Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Over 700 BioSimilars now in development worldwide: report

Reporter: Larry H. Bernstein, MD, FCAP

State of pharmaceutical development

UPDATED on 4/22/2021

Biosimilars: 3 key questions answered

What are Biosimilars?

Biosimilars are biological products such as proteins, peptides, monoclonal antibodies that are very similar in safety, efficacy, and purity to FDA approved medical products. They have the same active biological component while differ in terms of inactive components, manufacturing, and testing strategy. 

Why are Biosimilars used in research?

Analyzing the biological effects of any drug requires a large amount of the drug which is often challenging and expensive. This is especially true for pharmaceutical grade biotherapeutic drugs. Research grade biosimilars are tools for analyzing biological processes that negates the need to buy expensive therapeutic-grade biologics.

How are Biosimilars used in research?

Biosimilars can be used developments of small and large molecular biotherapeutics . These are routinely used in cell based assays and ligand binding studies.

OriGene offers 15 research grade biosimilars, monoclonal antibodies designed  for research use. 

List of research grade biosimilars

List of other tools for biosimilar research: